Tag: Ansa Biotechnologies

Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service

Ansa Biotechnologies Secures $54.4 Million in Series B Financing to Redefine How Scientists Access Synthetic DNA with Industry’s First Guaranteed On-Time Service

Funding enables company to scale its DNA synthesis services to meet accelerating demand and empower scientists to innovate across medicine, agriculture, and beyond EMERYVILLE, Calif.–(BUSINESS WIRE)–Ansa Biotechnologies, Inc., a trusted partner for DNA synthesis, today…

Read More Read More

Berkeley California based Ansa Biotechnologies is raising $9,213,151.00 in New Equity and Debt Financing.

Berkeley California based Ansa Biotechnologies is raising $9,213,151.00 in New Equity and Debt Financing.

Berkeley, CA – According to filings with the U.S. Securities and Exchange Commission, Ansa Biotechnologies is raising $9,213,151.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Daniel Lin-Arlow played a…

Read More Read More